Market Tracker

05/27 7:36am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

22.05
Delayed Data
As of May 26
 +0.31 / +1.43%
Today’s Change
13.10
Today|||52-Week Range
26.89
+30.78%
Year-to-Date

Today’s Trading

Previous close21.74
Today’s open21.77
Day’s range21.57 - 22.16
Volume535,718
Average volume (3 months)444,472
Market cap$637.0M
Dividend yield--
Data as of 05/26/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...-0.24-1.79%
INFIInfinity Pharmaceuti...+0.17+1.32%
CORTCorcept Therapeutics...-0.06-1.03%
OREXOrexigen Therapeutic...-0.06-1.30%
Data as of 05/26/2015

Financials

Next reporting dateJuly 22, 2015
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts